🇺🇸 FDA
Company

Monte

Monte Rosa Therapeutics

GLUE biotech USA

Quick answer

Monte is a biotech company (GLUE) headquartered in BOSTON, MA, USA with 5 tracked pipeline programs.

Pipeline (5)

project

Cabergoline 1 MG

Lactation Suppressed

Phase 2 · small_molecule · completed

1 trials project

Oral MRT-2359

NSCLC

Phase 2 · small_molecule · active

1 trials project

MRT-6160

Healthy Volunteers

Phase 1 · small_molecule · completed

1 trials project

MRT-8102

Healthy Volunteers

Phase 1 · small_molecule · active

1 trials project

Temozolomide

Brain Neoplasms, Malignant, Primary

Approved · small_molecule · completed

1 trials

Patents (8)

patent

US 12391663

Isoindolinone compounds

Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12378199

Rigidified pentadentate chelating agents useful for the [Al18F]2+ labelling of b

Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12280029

Methods of treatment of inflammation related conditions using pluripotent anti-i

Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12263143

Ionic channel modulation as a method for treating tumors through inflammasome ac

Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12257247

Targeted degradation of VAV1

Expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12214218

Perfusion modulated tumor dose sculpting with single dose radiotherapy

Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12070628

Low energy immune priming for treating cancer and metastasis

Expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12011619

Low intensity focused ultrasound for treating cancer and metastasis

Expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)